SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-004014
Filing Date
2017-05-09
Accepted
2017-05-09 16:52:52
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20170331x10q.htm 10-Q 1104873
2 EX-31.1 axsm-20170331ex311fa4a09.htm EX-31.1 11436
3 EX-31.2 axsm-20170331ex312e5ad3d.htm EX-31.2 11192
4 EX-32.1 axsm-20170331ex321a43bd2.htm EX-32.1 5903
5 EX-32.2 axsm-20170331ex32206d626.htm EX-32.2 5880
  Complete submission text file 0001558370-17-004014.txt   3136536

Data Files

Seq Description Document Type Size
6 EX-101.INS axsm-20170331.xml EX-101.INS 488523
7 EX-101.SCH axsm-20170331.xsd EX-101.SCH 25169
8 EX-101.CAL axsm-20170331_cal.xml EX-101.CAL 28520
9 EX-101.DEF axsm-20170331_def.xml EX-101.DEF 46466
10 EX-101.LAB axsm-20170331_lab.xml EX-101.LAB 225023
11 EX-101.PRE axsm-20170331_pre.xml EX-101.PRE 155707
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 17827255
SIC: 2834 Pharmaceutical Preparations